Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Paxlovid by Quarter
Paxlovid (nirmatrelvir/ritonavir oral COVID-19 treatment) — U.S. reported YoY (%) (%)
Pfizer Paxlovid: -100.0% in Q2 2026.
Latest, Q2 2026
-100.0%
Period ended Jun 28, 2026
Change on a year earlier
–
History
7 quarters
Since Q1 2023
Sources
7
Documents cited below
Where the Q2 2026 figure comes from
“|| Paxlovid | 21 | 427 | (95%) | (95%) | — | 328 | (100%) | 20 | 99 | (80%) | (81%)”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Reported in Form 8-K Revenue Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Paxlovid (nirmatrelvir/ritonavir oral COVID-19 treatment) — U.S. reported YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | -100.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | -61.0% | +20.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-3292026xex99.htm, filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | -78.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗ |
| Q3 2025 | Sep 28, 2025 | -52.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-09282025xex99.htm, filed 2025-11-04) ↗ |
| Q1 2025 | Mar 30, 2025 | -81.0% | -73.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-03302025xex99.htm, filed 2025-04-29) ↗ |
| Q1 2024 | Mar 31, 2024 | -8.0% | -101.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-3312024xex99.htm, filed 2024-05-01) ↗ |
| Q1 2023 | Apr 2, 2023 | 93.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-04022023xex99.htm, filed 2023-05-02) ↗ |
Cite this data
StockData. (2026). Pfizer Paxlovid (%), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/paxlovid-yoy-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.